Migrabeta Plus Tablet SR
By Migrabeta Plus
Rx
15 Tablet SR in a Strip

Composition
Propranolol(40mg) + Flunarizine(10mg)

Manufacturer - Alkem Laboratories Ltd
Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.

Expires on or after
April, 2027

liver
Caution is advised when using Migrabeta Plus Tablet SR in patients with liver disease. It may be necessary to adjust the dosage of the medication in such cases. It is important to consult with your doctor before taking Migrabeta Plus Tablet SR if you have liver issues. Regular monitoring of blood pressure is recommended to ensure the correct dose adjustments are made accordingly.

kidney
Migrabeta Plus Tablet SR is likely safe for patients with kidney disease. Limited data shows dose adjustment may not be necessary. Consult your doctor for guidance.

alcohol
It is not safe to drink alcohol when taking Migrabeta Plus Tablet SR to avoid harmful effects.

driving
Migrabeta Plus Tablet SR may lead to side effects like visual disturbances, hallucinations, fatigue, mental confusion, dizziness, or tiredness, impacting driving ability.

pregnancy
Migrabeta Plus Tablet SR is considered unsafe during pregnancy. Animal studies indicate potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing. It's important to consult your doctor regarding its use during pregnancy.

breastfeeding
It is better to consult your doctor before using Migrabeta Plus Tablet SR during breastfeeding.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | NEURO CNS |
| Action Class | - |
₹268.5
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024
